Annual Working Capital
$97.90 M
-$111.71 M-53.29%
December 31, 2023
Summary
- As of February 24, 2025, ACRS annual working capital is $97.90 million, with the most recent change of -$111.71 million (-53.29%) on December 31, 2023.
- During the last 3 years, ACRS annual working capital has risen by +$55.28 million (+129.72%).
- ACRS annual working capital is now -53.29% below its all-time high of $209.61 million, reached on December 31, 2022.
Performance
ACRS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$113.51 M
+$11.56 M+11.34%
September 30, 2024
Summary
- As of February 24, 2025, ACRS quarterly working capital is $113.51 million, with the most recent change of +$11.56 million (+11.34%) on September 30, 2024.
- Over the past year, ACRS quarterly working capital has increased by +$17.77 million (+18.55%).
- ACRS quarterly working capital is now -53.31% below its all-time high of $243.14 million, reached on June 30, 2022.
Performance
ACRS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ACRS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.3% | +18.6% |
| 3 y3 years | +129.7% | -39.6% |
| 5 y5 years | -35.7% | +6.7% |
ACRS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.3% | at low | -53.3% | +18.6% |
| 5 y | 5-year | -53.3% | +129.7% | -53.3% | +166.3% |
| alltime | all time | -53.3% | +652.0% | -53.3% | +1158.5% |
Aclaris Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $113.51 M(+11.3%) |
| Jun 2024 | - | $101.95 M(-11.5%) |
| Mar 2024 | - | $115.26 M(+17.7%) |
| Dec 2023 | $97.90 M(-53.3%) | $97.90 M(+2.3%) |
| Sep 2023 | - | $95.75 M(-13.0%) |
| Jun 2023 | - | $110.11 M(-33.7%) |
| Mar 2023 | - | $166.10 M(-20.8%) |
| Dec 2022 | $209.61 M(+15.1%) | $209.61 M(-11.5%) |
| Sep 2022 | - | $236.78 M(-2.6%) |
| Jun 2022 | - | $243.14 M(+39.6%) |
| Mar 2022 | - | $174.16 M(-4.4%) |
| Dec 2021 | $182.10 M(+327.3%) | $182.10 M(-3.1%) |
| Sep 2021 | - | $187.94 M(-17.0%) |
| Jun 2021 | - | $226.34 M(+88.6%) |
| Mar 2021 | - | $120.00 M(+181.6%) |
| Dec 2020 | $42.62 M(-30.6%) | $42.62 M(-5.7%) |
| Sep 2020 | - | $45.21 M(-15.0%) |
| Jun 2020 | - | $53.21 M(-14.3%) |
| Mar 2020 | - | $62.11 M(+1.2%) |
| Dec 2019 | $61.37 M | $61.37 M(-42.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $106.38 M(+11.8%) |
| Jun 2019 | - | $95.15 M(-21.1%) |
| Mar 2019 | - | $120.58 M(-20.7%) |
| Dec 2018 | $152.16 M(-18.8%) | $152.16 M(+23.5%) |
| Sep 2018 | - | $123.24 M(-18.4%) |
| Jun 2018 | - | $151.10 M(-15.3%) |
| Mar 2018 | - | $178.43 M(-4.8%) |
| Dec 2017 | $187.46 M(+41.7%) | $187.46 M(-16.4%) |
| Sep 2017 | - | $224.13 M(+33.9%) |
| Jun 2017 | - | $167.38 M(+10.3%) |
| Mar 2017 | - | $151.71 M(+14.6%) |
| Dec 2016 | $132.33 M(+55.7%) | $132.33 M(+63.4%) |
| Sep 2016 | - | $81.00 M(-10.1%) |
| Jun 2016 | - | $90.13 M(+8.5%) |
| Mar 2016 | - | $83.10 M(-2.2%) |
| Dec 2015 | $84.97 M(+470.9%) | $84.97 M(+126.8%) |
| Sep 2015 | - | $37.46 M(+315.3%) |
| Jun 2015 | - | $9.02 M(-39.4%) |
| Dec 2014 | $14.88 M(+14.3%) | $14.88 M |
| Dec 2013 | $13.02 M | - |
FAQ
- What is Aclaris Therapeutics annual working capital?
- What is the all time high annual working capital for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual working capital year-on-year change?
- What is Aclaris Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly working capital year-on-year change?
What is Aclaris Therapeutics annual working capital?
The current annual working capital of ACRS is $97.90 M
What is the all time high annual working capital for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual working capital is $209.61 M
What is Aclaris Therapeutics annual working capital year-on-year change?
Over the past year, ACRS annual working capital has changed by -$111.71 M (-53.29%)
What is Aclaris Therapeutics quarterly working capital?
The current quarterly working capital of ACRS is $113.51 M
What is the all time high quarterly working capital for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly working capital is $243.14 M
What is Aclaris Therapeutics quarterly working capital year-on-year change?
Over the past year, ACRS quarterly working capital has changed by +$17.77 M (+18.55%)